Clinical Trial Detail

NCT ID NCT03628066
Title Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements yes
Sponsors NSABP Foundation Inc
Indications

Her2-receptor negative breast cancer

Therapies

Goserelin + Letrozole + Palbociclib

Age Groups: adult senior

Additional content available in CKB BOOST